Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy J Purwin

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Nature Communications|November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma modelsConnor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Nature Communications|January 4, 2018
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanomaShujun Han, Yibo Ren, Wangxiao He, et al.
Nature Communications|April 8, 2018
Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanomaShujun Han, Yibo Ren, Wangxiao He, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP1 signaling in dormant disseminated uveal melanomaRama Kadamb, Melisa Lopez Anton, Timothy J Purwin, et al.
The Journal of Biological Chemistry|November 3, 2023
Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanomaUsman Baqai, Alison M Kurimchak, Isabella V Trachtenberg, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Molecular Cancer Research : MCR|December 21, 2018
Effects of Oncogenic Gα<sub>q</sub> and Gα<sub>11</sub> Inhibition by FR900359 in Uveal MelanomaDominic Lapadula, Eduardo Farias, Clinita E Randolph, et al.
Science Signaling|June 11, 2024
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stressVivian Chua, Melisa Lopez-Anton, Mizue Terai, et al.
Cancers|July 14, 2023
Co-Targeting FASN and mTOR Suppresses Uveal Melanoma GrowthAnna Han, Dzmitry Mukha, Vivian Chua, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Cancer Discovery|March 3, 2018
<i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Nature Communications|November 5, 2025
Targeting TAZ-TEAD in minimal residual disease enhances the duration of targeted therapy in melanoma modelsConnor A Ott, Timothy J Purwin, Pan-Yu Chen, et al.
Nature Communications|January 4, 2018
ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanomaShujun Han, Yibo Ren, Wangxiao He, et al.
Nature Communications|April 8, 2018
Publisher Correction: ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanomaShujun Han, Yibo Ren, Wangxiao He, et al.
Biorxiv : the Preprint Server for Biology|March 18, 2024
Lineage commitment pathways epigenetically oppose oncogenic Gαq/11-YAP1 signaling in dormant disseminated uveal melanomaRama Kadamb, Melisa Lopez Anton, Timothy J Purwin, et al.
The Journal of Biological Chemistry|November 3, 2023
Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanomaUsman Baqai, Alison M Kurimchak, Isabella V Trachtenberg, et al.
Cancer Discovery|December 5, 2018
Correction: <i>In Vivo</i> E2F Reporting Reveals Efficacious Schedules of MEK1/2-CDK4/6 Targeting and mTOR-S6 Resistance MechanismsJessica L F Teh, Phil F Cheng, Timothy J Purwin, et al.
Molecular Cancer Research : MCR|December 21, 2018
Effects of Oncogenic Gα<sub>q</sub> and Gα<sub>11</sub> Inhibition by FR900359 in Uveal MelanomaDominic Lapadula, Eduardo Farias, Clinita E Randolph, et al.
Science Signaling|June 11, 2024
Slow proliferation of BAP1-deficient uveal melanoma cells is associated with reduced S6 signaling and resistance to nutrient stressVivian Chua, Melisa Lopez-Anton, Mizue Terai, et al.
Cancers|July 14, 2023
Co-Targeting FASN and mTOR Suppresses Uveal Melanoma GrowthAnna Han, Dzmitry Mukha, Vivian Chua, et al.
Pageof 5